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so the Editor: Cardiac resynchronization therapy (CRT) via
oronary sinus (CS) lead placement has been shown to improve
eart failure (HF) symptoms (1–3). However, a 5% to 10%
mplant failure rate has resulted in alternative approaches for
ptimal CRT. Robotically assisted left ventricular (LV) epicardial
ead placement via the posterior approach was developed by our
roup as a minimally invasive rescue procedure for patients with
ailed CS leads (4). Our goal was to prospectively assess the
linical, electrophysiological, and echocardiographic effects of this
pproach at a median 15 months postoperatively.
Forty-two patients were referred for robotic LV lead implanta-
ion (Table 1). Demographic, operative, and post-operative data
ere collected and analyzed per institutional review board guide-
ines. All patients had been on maximal medical therapy for at least
hree months before CRT. Pre-operative evaluation consisted of
n electrocardiogram for verification of QRS 130 ms. Tissue
oppler imaging (TDI) was used to localize the latest site of
echanical activation in our last 10 patients with intraoperative
DI confirming resynchronization.
The technique used for robotically assisted LV lead placement
as been described previously (4). General anesthesia with selective
ight lung ventilation was used with patients positioned in the full
osterolateral thoracotomy position. The da Vinci robotic surgical
ystem was used for all portions of the surgery. A camera port was
laced in the seventh intercostal space (ICS) in the posterior
xillary line. The left and right arms were positioned in the ninth
nd fifth ICS, and a working port was inserted posterior to the
amera port, used for the introduction of leads and sutures.
Two leads were placed along the posterolateral LV surface using
he robotic arms. Pericardial closure with leads tunneled to the left
ubpectoral pocket occurred next. One lead, the active lead, was
onnected to the device and the second lead was left in the pocket
s a back-up lead. The remainder of the CRT system was
mplanted using standard transvenous techniques.
Patient follow-up occurred at a median 15 months (range, 3 to
4 months) (3-month intervals for device interrogation and within
months for echocardiograms). Response was defined as 1 New
ork Heart Association functional class improvement.
Table 1. Patient Profile
Age (yrs)
Etiology of heart failure (ischemic vs. nonischemic)
Gender (male/female)
New York Heart Association functional class
Left ventricular ejection fraction
Electrocardiographic rhythm
QRS duration (ms)
Optimal medical heart failure therapy*
Prior cardiac surgery
Primary/secondary therapy*Angiotensin-converting enzyme inhibitor/angiotensin receptor anPaired t testing and analysis of variance compared pre-operative
nd post-operative changes between groups. Cox regression anal-
sis determined predictors of response.
Eighty-four epicardial leads were placed. All patients had
uccessful lead placement within the targeted area. Intraoperative
ead threshold and R-wave were 0.8  0.5 V and 16  9 mV.
perative time was 51  32 min. Left ventricular injury and
leural adhesions necessitated conversion to mini-thoracotomy in
wo patients. When the learning curve of the first five cases was
emoved from analysis (108 55 min), operative time decreased to
5  13 min for the next 37 cases.
Patients were divided into two groups (first cardiac surgery
primary]) (n  21) and more than one prior cardiac surgery
re-op) (n  21). Although the re-op group manifested higher
ncidences of ischemic cardiomyopathy, diabetes mellitus, and age,
o significant differences (operative/follow-up) were found be-
ween the groups.
Discharge occurred at a mean of one postoperative day with no
erioperative mortality. In-hospital and 30-day complications
ncluded pneumonia (n  1), medically treated ischemic colitis
n  1), renal insufficiency (n  1), failure (n  1), urinary tract
nfection (n  1), intercostal neuropathy (n  2), and an infected
evice requiring explant (n  1).
The three-month clinical response rate was 81% (34 of 42) and
1% (30 of 42) at maximum follow-up (Fig. 1). Five deaths
ccurred, four patients experienced worsening HF, and three
atients experienced no change. One patient underwent cardiac
ransplantation.
Echocardiography at 12  7 months showed significant de-
reases in LV internal dimension index (LVIDI) systolic (s)
10%] and diastolic (d) [7%]. The LV ejection fraction
mproved by 7%.
Multivariate Cox regression analysis of various clinical and
chocardiographic parameters showed pulmonary hypertension
right-sided ventricular pressure35 mm Hg) was associated with
worse outcome (p  0.001).
Three patients experienced lead failures at 1, 9, and 14 months
econdary to failure of lead capture. Successful revision via the
econd lead was performed in these patients.
70  11
28 (67%)/14 (33%)
28 (67%)/14 (33%)
3.3  0.5
0.14  0.1
Sinus rhythm: 27 (64%); paced: 8 (19%);
atrial fibrillation: 7 (17%)
171  31
42 (100%)
21 (50%)
4 (10%)/38 (90%)tagonist/beta-adrenergic antagonist/loop diuretic.
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December 20, 2005:2358–9Successful CRT relies on accurate LV lead placement. Numer-
us investigators have shown that posterolaterally placed LV leads
esult in greater degrees of intraventricular resynchronization (5),
nd with TDI, the site for optimal lead placement may now be
etermined pre-operatively, therefore lead insertion techniques
hould aim to place leads in the most optimal zone for resynchro-
ization, a goal for alternative approaches for CRT.
Variations in CS venous tributaries remain the major limitation
or optimal CRT via percutaneous LV leads. A minimally invasive
pproach is particularly desirable in this setting. Limited thoracot-
my carries a morbidity of a rib spreading incision and limits lead
lacement options. Surgeons have championed thoracoscopic ap-
roaches to the LV for full surgical access to the entire epicardial
urface. The technical demands required for re-operative surgery
nd that with massive cardiomegaly have resulted in significant
onversion rates based on prior studies. In comparison, robotic
echnology affords complete LV access, and the three-dimensional
ision, scaled motion, and wrist-like mechanism allow for delicate
ericardial dissection during re-operative surgery and fine dissec-
ion in the limited working space afforded by these large hearts.
In all of the patients in this series, the desired site for LV pacing
as achieved. The 81% three-month response rate achieved in this
eries compares favorably to the 60% to 70% response rate reported
ith percutaneous CS LV lead placement (1–3), which may be
ttributed to 100% posterolateral lead placement in our patients.
owever, a non-responder rate did exist, and it is postulated that
ecause all patients presumably had maximal resynchronization,
ther factors, including severe LV dysfunction, can impact outcome.
Left ventricular reverse remodeling has been reported with
ercutaneous CRT and seems to be dependent on successful
esynchronization confirmed by TDI. This study is the first to
Figure 1. Clinical response at 3 and 15 months of follow-up.onfirm reverse remodeling in patients undergoing robotic surgicalRT. However, our data on TDI predicting clinical response is
oo limited to make any conclusions.
In summary, robotically assisted LV epicardial lead implanta-
ion is a safe and effective technique for CRT in all patients.
linical response rates and LV remodeling data compare favorably
ith those achieved with CS leads. It is an invaluable technique
llowing for minimally invasive rescue therapy after failed CS
eads. Its role in primary implantation awaits further study.
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